Reversal of Residual Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine
Clinical trial NCT03656614 · COMPLETED
Trial details
- NCT number
- NCT03656614
- Sponsor
- Guangzhou General Hospital of Guangzhou Military Command
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-26
- Primary completion
- 2019-06-28
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.